Video

How Can Access to Costly Specialty Drugs be Improved?

Author(s):

Lauren Santye, Assistant Editor

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.

Related Videos
Related Content
Hemoglobin deficiency and red blood cell anemia | Image Credit: © loran4a - stock.adobe.com
December 25th 2024

Gecacitinib Demonstrates Safety, Efficacy Over Hydroxyurea in Patients With Myelofibrosis and Anemia

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Bladder and prostate stamped on wooden cubes, prostate cancer, bladder cancer, male healthcare concept, regular prostate checkup.
December 23rd 2024

FDA Approves Vibegron for Men With Overactive Bladder Symptoms Receiving Therapy for Benign Prostatic Hyperplasia

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

ASHP Midyear: Vaccination Among Older Adults Prevents Severe RSV Infections
December 23rd 2024

ASHP Midyear: Vaccination Among Older Adults Prevents Severe RSV Infections

FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog
December 21st 2024

FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog

Aislinn Antrim, Assistant Managing Editor